StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Are we dead in the water here?

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jan 16, 2023 5:51pm

122 Views

Post# 35226662

RE:RE:RE:Are we dead in the water here?

Why you think that?

1) They have access to $25 million they dont need a r/s to get the share price up.
2) They just extended warranted why do that if they were going to do a r/s.
3) if they wanted a r/s vote they could have waited until the general meeting in May/June why call a special meeting for Feb.

It still costs money to send out proxy docs and have a vote. Why have 2 meetings and votes a few months apart.

Something else.